LUXEMBOURG–(BUSINESS WIRE)–Regulatory Information:
Eurofins (Paris:ERF):
Eurofins Scientific (EUFI.PA), a world chief in BioPharma Product Testing, proclaims the closing of its acquisition of Infinity Laboratories, Inc. (Infinity). Based in 1991, Infinity operates eight state-of-the-art laboratories throughout america and employs roughly 100 employees. Infinity’s vital microbiology testing footprint with best-in-class programs offers native providers in key areas of the nation, increasing the Eurofins microbiology footprint. The corporate additionally affords chemistry, sterilisation, and bundle testing to pharmaceutical, biotechnology and medical gadget purchasers. Its bundle testing providers in California present a great complement to Eurofins’ Pennsylvania-based bundle testing providers. Infinity’s core competencies, consumer relationships, and geographic protection additionally complement and improve the Eurofins community’s intensive portfolio in BioPharma Product Testing and Medical System Testing providers to purchasers throughout america and world wide.
The acquisition additional bolsters the Eurofins BioPharma and Medical System Testing community’s nationwide and international footprint to offer essentially the most complete and aggressive service providing within the trade. In return, Infinity and its purchasers acquire entry to Eurofins’ intensive laboratory community, analytical portfolio and main IT programs.
Remark from Dr Gilles Martin, Eurofins CEO: “We’re more than happy to welcome Infinity’s groups to Eurofins. The addition of Infinity’s laboratories and competencies to Eurofins’ main BioPharma Companies community of corporations additional will increase our management in offering essentially the most revolutionary, high-quality and cost-competitive providers and IT programs to our purchasers.
About Eurofins “ the worldwide chief in bio-analysis
Eurofins is Testing for Life. The Eurofins Scientific S.E. community of unbiased corporations believes that it’s a international chief in meals, setting, pharmaceutical and beauty product testing and in discovery pharmacology, forensics, superior materials sciences and agroscience contract analysis providers. It is usually one of many market leaders in sure testing and laboratory providers for genomics, and within the assist of medical research, in addition to in biopharma contract improvement and manufacturing. It additionally has a quickly growing presence in extremely specialised and molecular medical diagnostic testing and in-vitro diagnostic merchandise.
With ca. 62,000 employees throughout a decentralised and entrepreneurial community of greater than 900 laboratories in over 1,000 corporations in 62 international locations, Eurofins affords a portfolio of over 200,000 analytical strategies to judge the protection, id, composition, authenticity, origin, traceability and purity of a variety of merchandise, in addition to offering revolutionary medical diagnostic testing providers and in-vitro diagnostic merchandise.
Eurofins corporations’ broad vary of providers are vital for the well being and security of individuals and our planet. The continuing funding to develop into absolutely digital and keep the perfect community of state-of-the-art laboratories and tools helps our goal to offer our clients with high-quality providers, revolutionary options and correct ends in the absolute best turnaround time (TAT). Eurofins corporations are properly positioned to assist purchasers’ more and more stringent high quality and security requirements and the rising calls for of regulatory authorities in addition to the evolving necessities of healthcare practitioners world wide.
The Eurofins community has grown very strongly since its inception and its technique is to proceed increasing its expertise portfolio and its geographic attain. By R&D and acquisitions, its corporations draw on the most recent developments within the area of biotechnology and analytical chemistry to supply their purchasers distinctive analytical options.
Shares in Eurofins Scientific S.E. are listed on the Euronext Paris Inventory Alternate (ISIN FR0014000MR3, Reuters EUFI.PA, Bloomberg ERF FP).
About Infinity
Infinity Laboratories was based in 1991 as a regional microbiology laboratory dedicated to high quality options and buyer success. Immediately, Infinity has expanded into eight amenities throughout america to proudly serve its pharmaceutical, biotechnology and medical gadget companions with the mixed flexibility and buyer engagement of an area companion and the best-in-class programs of a coast-to-coast community.
View supply model on businesswire.com: https://www.businesswire.com/information/residence/20240915133411/en/
Notes to Editors:
For extra info, please go to www.eurofins.com or contact:
Investor Relations
Eurofins Scientific SE
Cellphone: +32 2 766 1620
E-mail: ir@sc.eurofinseu.com
Supply: Eurofins Scientific SE
